MedTrace Logo

Evaluation of Sarcopenia With SARC-F and Anthropometric Measurement

NCT05241886 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 190

Last updated 2022-03-07

No results posted yet for this study

Summary

The aim of this study is to examine the performance of determining the sarcopenia by anthropometric measurements (mid-upper arm circumference and calf circumference) added to the SARC-F questionnaire developed as a screening tool for the risk of sarcopenia in the community-dwelling older adults. The risk of sarcopenia of the individuals over 65 years of age who applied to the Geriatrics Department of Ege University Medical Faculty Hospital Internal Diseases Department. was determined by the SARC-F questionnaire, muscle mass was established by bioelectrical impedance analysis, muscle strength was assessed by handgrip strength, physical performance was assessed by a 4-meter walking test and presence of malnutrition was assessed with an MNA-long form. For the diagnosis of sarcopenia; old (EWGSOP 1) and revised (EWGSOP 2) diagnostic criteria of Sarcopenia Study Group in Elderly Individuals of the European Union Geriatric Medicine Association were used. New parameters were obtained by adding calf circumference (SARC-CC) and mid-upper arm circumference (SARC-MUAC) measurements were added separately and together (SARC-CC-MUAC) to the SARC-F. For the calf circumference cut-off points of \<31 cm and \<33 cm and for the mid-upper arm circumference cut-off points of \<25 cm and \<31 cm were used for the sensitivity and specificity analyses.

Conditions

Interventions

OTHER

anthoropometric measurement, SARC- F questionnare

SARC-F, CC, MUAC

Sponsors & Collaborators

  • Ege University

    lead OTHER

Principal Investigators

  • yasemin A Atik-Altinok, PhD · Ege University

  • Devrim Bozkurt, Assoc Prof · Ege University

  • Sumru Savaş, Assoc Prof · Ege University

  • Reci Meseri, Assoc Prof · Ege University

  • Fulden Saraç, Prof Dr · Ege University

  • Fehmi Akçiçek, Prof Dr · Ege University

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2019-03-02
Completion
2019-05-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05241886 on ClinicalTrials.gov